What is the recommended updated therapy for syphilis across its stages?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Updated Therapy for Syphilis

Benzathine penicillin G remains the definitive treatment for all stages of syphilis, with dosing determined by disease stage: a single 2.4 million unit IM injection for early syphilis (primary, secondary, and early latent), and three weekly doses of 2.4 million units IM for late latent and tertiary syphilis. 1

Treatment by Stage

Primary and Secondary Syphilis

  • Standard regimen: Benzathine penicillin G 2.4 million units IM as a single dose 1
  • Treatment success rates: 90-100% 2
  • For HIV-infected patients: Same single-dose regimen is recommended, though some experts suggest additional doses 3, 4
    • Recent evidence shows no significant benefit to multiple doses in HIV-infected patients based on serologic outcomes 4
    • However, closer follow-up is warranted (at 1,2,3,6,9, and 12 months) 3

Early Latent Syphilis (< 1 year duration)

  • Standard regimen: Benzathine penicillin G 2.4 million units IM as a single dose 1
  • HIV-infected patients should be managed identically to those with primary/secondary syphilis 5

Late Latent and Tertiary Syphilis

  • Standard regimen: Benzathine penicillin G 7.2 million units total, administered as three doses of 2.4 million units IM at weekly intervals 1, 3
  • Patients with symptomatic late syphilis require CSF examination before initiating therapy 1, 3
  • Cardiovascular syphilis may warrant neurosyphilis treatment regimens in consultation with specialists 1

Neurosyphilis

  • Standard regimen: Aqueous crystalline penicillin G 18-24 million units per day IV (administered as 3-4 million units every 4 hours or continuous infusion) for 10-14 days 1
  • Alternative regimen (if compliance assured): Procaine penicillin 2.4 million units IM once daily PLUS probenecid 500 mg orally four times daily, both for 10-14 days 1
  • Some specialists add benzathine penicillin 2.4 million units IM weekly for up to 3 weeks after completing neurosyphilis treatment to provide comparable total duration 1
  • Critical: Syphilitic uveitis or other ocular manifestations must be treated as neurosyphilis with CSF examination 1

Alternative Regimens for Penicillin Allergy

Early Syphilis (Primary, Secondary, Early Latent)

  • Doxycycline 100 mg orally twice daily for 14 days 1, 4, 6
    • Recent systematic review and network meta-analysis supports doxycycline as the best-supported alternative (pooled OR 6.88 favoring doxycycline) 6
  • Tetracycline 500 mg orally four times daily for 14 days 1, 3
  • Ceftriaxone 1 g IV/IM daily for 10 days is a reasonable alternative based on randomized trial data 4
  • Azithromycin is NOT recommended due to widespread macrolide resistance in the United States, despite some efficacy data 4, 7, 8

Late Latent Syphilis

  • Doxycycline 100 mg orally twice daily for 28 days 1
  • Tetracycline 500 mg orally four times daily for 28 days 1
  • CSF examination must exclude neurosyphilis before using non-penicillin therapy 1, 3
  • Close serologic and clinical follow-up is essential 1

Neurosyphilis

  • No acceptable alternatives exist 3
  • Penicillin-allergic patients must undergo desensitization and receive penicillin 3

Special Populations

Pregnancy

  • All pregnant patients must receive penicillin regardless of allergy status 5, 1, 3
  • Penicillin-allergic pregnant women require desensitization followed by stage-appropriate penicillin regimen 5, 1, 3
  • Some experts recommend a second dose of benzathine penicillin 2.4 million units IM one week after initial dose for primary, secondary, or early latent syphilis in pregnancy 5, 3
  • Screening requirements: Early pregnancy, 28 weeks gestation, and at delivery in high-prevalence populations 5, 3
  • Women treated in the second half of pregnancy risk premature labor from Jarisch-Herxheimer reaction 5, 3

HIV-Infected Patients

  • Primary/Secondary/Early Latent: Same single-dose benzathine penicillin G 2.4 million units IM 3
  • Late Latent: CSF examination required before treatment; if normal, treat with benzathine penicillin G 7.2 million units (three weekly doses) 5, 3
  • Penicillin must be used for all stages—desensitization if allergic 5, 3
  • More intensive follow-up required due to potential treatment failure 5, 3

Follow-Up and Treatment Failure

Early Syphilis

  • Serologic testing at 6 and 12 months 1
  • HIV-infected: 1,2,3,6,9, and 12 months 3
  • Treatment failure criteria: Fourfold increase in titers, failure of initially high titer (≥1:32) to decline fourfold within 12-24 months, or new clinical symptoms 5, 1

Late Latent Syphilis

  • Serologic testing at 6,12,18, and 24 months 5
  • Same treatment failure criteria apply 1

Management of Treatment Failure

  • Perform CSF examination 5, 1
  • Re-treat with benzathine penicillin G 7.2 million units (three weekly doses) if CSF is normal 5, 1
  • Treat as neurosyphilis if CSF abnormalities present 5, 1

Critical Caveats

Benzathine penicillin G shortages: Ongoing global supply issues necessitate awareness of alternative regimens, though penicillin remains superior 8, 9, 10

Serofast state: A significant proportion of patients remain seropositive after treatment; this does not necessarily indicate treatment failure if titers have declined appropriately 1, 2

Serologic response timing: Expect response by 6 months for early syphilis but 12-24 months for latent syphilis 2

Partner notification: All sexual contacts within 90 days for primary syphilis, 6 months for secondary, and 1 year for early latent must be evaluated and treated 1

Prevention strategies: Doxycycline 200 mg within 72 hours after sex as post-exposure prophylaxis is recommended for MSM and transgender women with recent STI history 11, 8, 9

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.